Free Trial

Prelude Therapeutics (PRLD) Insider Trading & Ownership

→ Move Your Money Before May 1 (From Stansberry Research) (Ad)
Free PRLD Stock Alerts
$4.07
+0.03 (+0.74%)
(As of 04/26/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Prelude Therapeutics (NASDAQ:PRLD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
79.54%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$5.01 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get PRLD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Prelude Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

PRLD Insider Buying and Selling by Quarter

Ad Stansberry Research
Move Your Money Before May 1
Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens?
Click here to get the full story before May 1. 

Prelude Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/24/2023Krishna VaddiCEOBuy1,000$5.01$5,010.00  
5/22/2023Orbimed Advisors LlcDirectorBuy869,565$5.75$4,999,998.75  
(Data available from 1/1/2013 forward)

PRLD Insider Trading Activity - Frequently Asked Questions

Who is on Prelude Therapeutics's Insider Roster?

The list of insiders at Prelude Therapeutics includes Andrew Combs, Brian Piper, Christopher Pierce, David J Mauro, Deborah Morosini, Jane Huang, Krishna Vaddi, Laurent Chardonnet, Orbimed Advisors Llc, and Peggy Scherle. Learn more on insiders at PRLD.

What percentage of Prelude Therapeutics stock is owned by insiders?

79.54% of Prelude Therapeutics stock is owned by insiders. Learn more on PRLD's insider holdings.

Which Prelude Therapeutics insiders have been buying company stock?

The following insiders have purchased PRLD shares in the last 24 months: Krishna Vaddi ($103,444.44), Laurent Chardonnet ($89,900.00), and Orbimed Advisors Llc ($4,999,998.75).

How much insider buying is happening at Prelude Therapeutics?

Insiders have purchased a total of 909,753 PRLD shares in the last 24 months for a total of $5,193,343.19 bought.

Which Prelude Therapeutics insiders have been selling company stock?

The following insider sold PRLD shares in the last 24 months: Jane Huang ($81,273.60).

How much insider selling is happening at Prelude Therapeutics?

Insiders have sold a total of 13,280 Prelude Therapeutics shares in the last 24 months for a total of $81,273.60 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:PRLD) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners
These AI trades triggered this morning (545% return)
Prosper Trading Academy
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years
Banyan Hill Publishing
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Fed launches fourth dollar overhaul
Stansberry Research
Man Who Predicted 2008: “This Will be Worse.”
Altimetry